During the past decade, Tower Urology conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tower Urology" #1 sponsor was "Blue Earth Diagnostics" with 3 trials, followed by "Allergan" with 2 trials sponsored, "Clarus Therapeutics, Inc." with 2 trials sponsored, "Veru Inc." with 2 trials sponsored and "Allena Pharmaceuticals" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tower Urology" #1 collaborator was "Parexel" with 2 trials as a collaborator, "American College of Radiology" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "IND 2 Results LLC" with 1 trials as a collaborator and "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Tower Urology" are "Prostate Cancer" (7 trials), "Bladder Cancer" (2 trials), "Male Hypogonadism" (2 trials), "Prostate Cancer Metastatic" (2 trials) and "Urinary Incontinence" (2 trials). Many other conditions were trialed in "Tower Urology" in a lesser frequency.

Most popular intervention types in "Tower Urology" are "Drug" (19 trials), "Biological" (2 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Oral testosterone undecanoate" (2 trials), "rhPSMA-7.3 (18F) Injection" (2 trials), "18F-DCFPyL" (1 trials) and "18F-fluciclovine PET CT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tower Urology" are 16 trials for "Male" genders, 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tower Urology". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Tower Urology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tower Urology, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Tower Urology has several departments that took part in Clinical trials: "Tower Urology / Tower Research Institute" - 2 trials